Search research articles
Contact Us
Filters
Showing results (11-20 of 111) with videos related to
Page
of 12
Sort By:
Frontiers in Aging Neuroscience
|
May 15, 2026
Systemic delivery of anti-sense oligonucleotide targeting α-synuclein for treatment in a mouse model of multiple system atrophy
Brian Spencer, Bao Quach, Sahar Salehi, et al.
Plos One
|
September 29, 2021
Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression
Jennifer Grundman, Brian Spencer, Floyd Sarsoza, et al.
Research Square
|
November 24, 2025
Systemic delivery of anti-sense oligonucleotide targeting a-synuclein for the treatment of multiple system atrophy
Brian Spencer, Bao Quach, Sahar Salehi, et al.
Neurobiology of Disease
|
May 10, 2025
Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology
Brian Spencer, Aaron Schueler, Daniel Sung, et al.
Expert Opinion on Biological Therapy
|
November 24, 2007
Novel strategies for Alzheimer's disease treatment
Brian Spencer, Edward Rockenstein, Leslie Crews, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 25, 2012
Cell-to-cell transmission of α-synuclein aggregates
Seung-Jae Lee, Paula Desplats, He-Jin Lee, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Anti-Sense Oligonucleotide as a Therapeutic for Synucleinopathies: Pharmacokinetic, Safety and Efficacy Evaluation
Rijwan U Ahammad, Brian Spencer, Bao Quach, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 22, 2026
Peptide-mediated delivery of an α-synuclein-targeting antisense oligonucleotide: Pharmacokinetics, safety, and central nervous system efficacy in a synucleinopathy model
Rijwan U Ahammad, Bao Quach, Sahar Salehi, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 25, 2025
A splice-switching antisense oligonucleotide targeting APP reduces accumulation of α-synuclein in a mouse model of Parkinson's disease
Rijwan U Ahammad, Brian Spencer, Bao Quach, et al.
Molecular Neurodegeneration
|
September 24, 2015
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy
Brian Spencer, Elvira Valera, Edward Rockenstein, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 111) with videos related to
Sort By:
Page
of 12
Frontiers in Aging Neuroscience
|
May 15, 2026
Systemic delivery of anti-sense oligonucleotide targeting α-synuclein for treatment in a mouse model of multiple system atrophy
Brian Spencer, Bao Quach, Sahar Salehi, et al.
Plos One
|
September 29, 2021
Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression
Jennifer Grundman, Brian Spencer, Floyd Sarsoza, et al.
Research Square
|
November 24, 2025
Systemic delivery of anti-sense oligonucleotide targeting a-synuclein for the treatment of multiple system atrophy
Brian Spencer, Bao Quach, Sahar Salehi, et al.
Neurobiology of Disease
|
May 10, 2025
Differential roles of human tau isoforms in the modulation of inflammation and development of neuropathology
Brian Spencer, Aaron Schueler, Daniel Sung, et al.
Expert Opinion on Biological Therapy
|
November 24, 2007
Novel strategies for Alzheimer's disease treatment
Brian Spencer, Edward Rockenstein, Leslie Crews, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 25, 2012
Cell-to-cell transmission of α-synuclein aggregates
Seung-Jae Lee, Paula Desplats, He-Jin Lee, et al.
Biorxiv : the Preprint Server for Biology
|
July 14, 2025
Anti-Sense Oligonucleotide as a Therapeutic for Synucleinopathies: Pharmacokinetic, Safety and Efficacy Evaluation
Rijwan U Ahammad, Brian Spencer, Bao Quach, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 22, 2026
Peptide-mediated delivery of an α-synuclein-targeting antisense oligonucleotide: Pharmacokinetics, safety, and central nervous system efficacy in a synucleinopathy model
Rijwan U Ahammad, Bao Quach, Sahar Salehi, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 25, 2025
A splice-switching antisense oligonucleotide targeting APP reduces accumulation of α-synuclein in a mouse model of Parkinson's disease
Rijwan U Ahammad, Brian Spencer, Bao Quach, et al.
Molecular Neurodegeneration
|
September 24, 2015
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy
Brian Spencer, Elvira Valera, Edward Rockenstein, et al.
Page
of 12